WeVote
Log In

Bill

Bill

RS 494

Para enmendar la Sección 3 de la Resolución del Senado 319, según aprobada el 3 de noviembre de 2025, que le ordena a la Comisión de Salud del Senado de Puerto Rico realizar una investigación exhaustiva sobre el efecto e impacto de la Ley Núm. 42 2017, según enmendada, conocida como “Ley para Manejar el Estudio, Desarrollo e Investigación del Cannabis para la Innovación, Normas Aplicables y Límites (“Ley MEDICINAL”)”, evaluando el cumplimiento de la Junta Reglamentadora del Cannabis Medicinal con los deberes que le impone la Ley, así como la transparencia, efectividad y resultados del sistema de cannabis medicinal en Puerto Rico en sus aspectos administrativos, regulatorios, científicos y socioeconómicos, incluyendo su impacto en la creación de empleos, la salud y calidad de vida de los pacientes.

2025-2028 Session

The bill directs a 120-day, time-limited Senate investigation into how well Puerto Rico’s medicinal cannabis framework, including the Cannabis Regulatory Board, works for patients,

Texto de Aprobación Final en Senado
0
WeVote Research Nonpartisan
Bill Summary · RS 494

Summary of Bill RS 494 (Session 2025-2028, Puerto Rico)

Overall purpose

Bill RS 494 proposes to amend Section 3 of Senate Resolution 319 (as approved November 3, 2025). The core aim is to direct the Senate’s Health Committee to conduct an exhaustive investigation into the effects and impact of Puerto Rico’s medicinal cannabis framework (Law No. 42-2017, as amended), known as the “Medicinal Cannabis Law.” The investigation would assess:

  • Compliance of the Cannabis Regulatory Board (Junta Reglamentadora del Cannabis Medicinal) with the duties imposed by the law
  • Transparency, effectiveness, and results of Puerto Rico’s medicinal cannabis system across administrative, regulatory, scientific, and socio-economic dimensions
  • Impact on job creation
  • Health and quality of life of patients

Key provisions

  • Section 1 (Amendment to Resolution 319):

    • Section 3 of Senate Resolution 319 is amended to change the reporting deadline.
    • The Senate must render a report outlining findings, conclusions, and recommendations within a specified timeframe: 120 days from the approval of RS 494.
    • The report must be delivered before the end of the Legislature’s Third Ordinary Session.

  • Section 2 (Effective date):

    • The resolution enters into force immediately upon approval.

Who/what is affected

  • Regulatory and oversight bodies: The Cannabis Regulatory Board (Junta Reglamentadora del Cannabis Medicinal) and its compliance with the law (Law No. 42-2017, as amended).
  • Public health and regulatory agencies: Entities involved in supervising, implementing, and evaluating the medicinal cannabis program.
  • Patients and healthcare outcomes: Indirectly affected through the evaluation of health impacts, access, and quality of life.
  • Economic and labor landscape: Impacts on employment related to the medicinal cannabis sector (growers, processors, distributors, clinics, and ancillary services).

Procedural and timeline aspects

  • The amendment shortens or specifies a reporting deadline of 120 days from RS 494’s approval.
  • The required report must be submitted before the conclusion of the Third Ordinary Session.
  • The measure becomes effective immediately upon approval, triggering the new reporting obligation.

Potential impact and considerations

  • Could yield a formal, time-bound assessment of the medicinal cannabis program’s performance and governance.
  • May influence policy decisions, regulatory reforms, or enhancements to transparency and accountability within the Cannabis Regulatory Board.
  • Findings could affect future legislation, funding allocations, and program improvements aimed at patient care, safety, and socio-economic outcomes.

If you’d like, I can add a brief outline of possible data points or metrics the committee might review (e.g., licensing timelines, compliance statistics, patient access metrics, adverse event reporting, employment figures, and patient health outcomes).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.